Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4868442
Max Phase: Preclinical
Molecular Formula: C48H62N3O12P
Molecular Weight: 904.01
Molecule Type: Unknown
Associated Items:
ID: ALA4868442
Max Phase: Preclinical
Molecular Formula: C48H62N3O12P
Molecular Weight: 904.01
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOP(=O)(/C=C/[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3)NC(=O)OCc1ccccc1)c1ccccc1)OCC
Standard InChI: InChI=1S/C48H62N3O12P/c1-6-58-64(55,59-7-2)28-26-39(36-21-15-10-16-22-36)49-42(52)40(29-34-17-11-8-12-18-34)50-43(53)41(51-46(54)57-30-35-19-13-9-14-20-35)31-56-44-33(4)38-24-23-32(3)37-25-27-47(5)61-45(60-44)48(37,38)63-62-47/h8-22,26,28,32-33,37-41,44-45H,6-7,23-25,27,29-31H2,1-5H3,(H,49,52)(H,50,53)(H,51,54)/b28-26+/t32-,33-,37+,38+,39-,40+,41+,44+,45-,47-,48-/m1/s1
Standard InChI Key: GYDOICOTTKBGPW-QEKQBXGYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 904.01 | Molecular Weight (Monoisotopic): 903.4071 | AlogP: 7.87 | #Rotatable Bonds: 19 |
Polar Surface Area: 178.21 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.99 | CX Basic pKa: | CX LogP: 7.57 | CX LogD: 7.57 |
Aromatic Rings: 3 | Heavy Atoms: 64 | QED Weighted: 0.08 | Np Likeness Score: 1.16 |
1. Aratikatla EK, Kalamuddin M, Rana KC, Datta G, Asad M, Sundararaman S, Malhotra P, Mohmmed A, Bhattacharya AK.. (2021) Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials., 220 [PMID:33901900] [10.1016/j.ejmech.2021.113454] |
Source(1):